Bayer Aktiengesellschaft (WSE:BAY)
Poland · Delayed Price · Currency is PLN | Market Cap | 160.75B +68.0% |
| Revenue (ttm) | 192.30B -2.2% |
| Net Income | -15.27B |
| EPS | -15.55 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 9.06 |
| Dividend | 0.47 (0.28%) |
| Ex-Dividend Date | Apr 28, 2025 |
| Volume | n/a |
| Average Volume | 96 |
| Open | 167.00 |
| Previous Close | 167.00 |
| Day's Range | 167.00 - 167.00 |
| 52-Week Range | 79.48 - 198.18 |
| Beta | n/a |
| RSI | 46.23 |
| Earnings Date | Mar 4, 2026 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge... [Read more]
Financial Performance
In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.
Financial numbers in EUR Financial StatementsNews
Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada launches Advancing Better Canola (ABCs), an industry-wide initiative to challenge and redefine how it thinks about canola innovation in sup...
Activist investor Inclusive Capital looks to sell stake in Bayer, Bloomberg News reports
Inclusive Capital Partners is looking to sell a stake in German agriculture and health firm Bayer AG , Bloomberg News reported on Monday.
Bayer Crop Science Launches 2026 Opportunity Scholarship Program
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada is excited to support the future of Canadian agriculture with its 2026 Bayer Crop Science Opportunity Scholarship. Through the scholarship,...
Bayer takes its multi-front battle on pesticide liability to Kansas
Kansas lawmakers were set to take up a bill on Tuesday backed by Bayer that would prevent people from suing pesticide manufacturers for not warning them that their products could cause cancer or othe...
Bayer's $7.25 billion Roundup settlement gets initial OK from Missouri judge
A state court judge in Missouri gave an initial green light on Wednesday to a proposed $7.25 billion settlement to resolve thousands of lawsuits claiming Bayer's Roundup weedkiller causes cancer.
New FDA 510(k) Clearance Expands Bayer's MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for expanded capabilities of its MEDRAD® MRXperion Magnetic Resonance (...
Bayer Net Loss Widens on Weedkiller Litigation Charges
The agriculture and pharmaceutical company reported a steeper net loss, including a €3.55 billion hit mainly from litigation-related expenses.
Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
BERLIN--(BUSINESS WIRE)--Bayer today announced results from the ongoing global Phase I first-in-human, dose-escalation PAnTHa study (NCT06217822) evaluating the safety, tolerability and preliminary ef...
Bayer's XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer's XOFIGO® plus enzalutamide demonstrates significant OS benefit in PEACE-3 trial in patients with mCRPC with bone metastases.
Some roundup plaintiffs seek to delay preliminary approval of proposed $7.25 bln bayer settlement, court filing shows
Law firms representing nearly 20,000 people who sued Bayer over alleged injuries from its Roundup weedkiller urged a Missouri judge on Wednesday to delay reviewing the German company's proposed $7.25 ...
Bayer files lawsuit against Johnson & Johnson, Janssen Biotech
German pharmaceutical company Bayer said on Monday that it had filed a lawsuit in a New York court against Johnson & Johnson and Janssen Biotech Inc related to its Nubeqa prostate cancer drug.
Bayer Alleges J&J's Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J's ERLEADA
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that it has filed suit against Johnson & Johnson (J&J) and Janssen Biotech, Inc. in the United States District Court for the Southern District of...
Bayer, John Deere Further Integrate FieldView and Operations Center to Improve Customer Experience for 2026 Season
ST. LOUIS--(BUSINESS WIRE)--Bayer and John Deere today announced a new capability that simplifies how U.S. farmers and advisors move from agronomic decisions to precise execution in the field. Beginni...
Voyageur Pharmaceuticals Announces Collaboration with Bayer
Calgary, Alberta, Canada – TheNewswire – February 23, 2026 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM) ( OTC Pink:VYYRF) (" Voyageur " or the " Company ") a Canadian developer of pharmaceutical-grade ...
Bayer proposes $7.25 billion Roundup settlement as Supreme Court case looms
A new $7.25 billion settlement between Bayer and a group of cancer patients could wrap up a huge wave of lawsuits against the company over allegations that it didn't warn consumers about cancer risks ...
Bayer: glyphosate shortages not expected outside the US after executive order
The U.S. President's executive order invoking the Defense Production Act to ensure U.S. supply of glyphosate underscores U.S. farmers' needs to have access to the herbicide, Bayer said on Thursday, ad...
Explainer: Will Bayer's proposed $7.25 billion Roundup deal bring legal closure?
Bayer's Monsanto unit has proposed a $7.25 billion nationwide class settlement to resolve both current and future lawsuits alleging that its Roundup weedkiller caused cancer, billing it as a long-awai...
Bayer retreats as investors sour on deal to settle Roundup litigation
Bayer's shares slumped as much as 9.2% on Wednesday, wiping out the previous day's gains, as investors questioned whether a proposed $7.25 billion settlement of cancer lawsuits over its Roundup weedki...
Bayer shares make this surprising move after $7.25 billion Roundup settlement accord
Bayer stock slumped on Wednesday as the German giant set a preliminary accord to cap litigation over its weedkiller Roundup.
Bayer falls 7% after proposing $7.25 billion settlement in Roundup case; European markets open higher
European stocks opened higher on Wednesday as investors monitor global market developments.
Bayer agrees to pay $7.25bn to settle Roundup weedkiller cancer lawsuits
Thousands of lawsuits accuse the agrochemical maker of failing to warn people that its weedkiller could cause cancer
Bayer Proposes New $7 Billion Plan to Settle Roundup Litigation
Company says settlement would address bulk of outstanding cases; the Supreme Court has agreed to hear Bayer's appeal to neutralize cancer claims.
Bayer CEO says Roundup settlement is important addition to Supreme Court case
Bayer's U.S. class settlement aimed at resolving current and future claims that Roundup weedkiller caused non‑Hodgkin lymphoma is an important addition to its Supreme Court case, Bayer CEO Bill Anders...
Bayer to make $10.5 bln push to settle roundup cases, Bloomberg reports
Bayer is planning to announce a $10.5 billion settlement push to settle current and future cancer lawsuits over its Roundup weedkiller, Bloomberg reported on Tuesday, citing people familiar with the p...
Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month
WHIPPANY, N.J.--(BUSINESS WIRE)--This American Heart Month, Bayer® Aspirin continues its mission to help people uncover the heart health risk factors they may not see with the launch of the Heart to H...